Ovarian hyperstimulation syndrome
- PMID: 39251242
- PMCID: PMC11383550
- DOI: 10.1503/cmaj.240213
Ovarian hyperstimulation syndrome
Conflict of interest statement
Competing interests:: Hans Rosenberg reports payment for expert testimony from the Canadian Medical Protective Association and travel support from Canadian Women in Medicine. Bryden Magee reports payment from BioSyent as an advisory board member. No other competing interests were declared.
References
-
- Timmons D, Montrief T, Koyfman A, et al. . Ovarian hyperstimulation syndrome: a review for emergency clinicians. Am J Emerg Med 2019;37:1577–84. - PubMed
-
- Shmorgun D, Claman P. No. 268: The diagnosis and management of ovarian hyperstimulation syndrome. J Obstet Gynaecol Can 2017;39:e479–86. - PubMed
-
- Canadian Assisted Reproductive Technologies Register Plus (CARTR Plus). Canadian Fertility and Andrology Society. Toronto, Ontario, 65th Annual Meeting; 2023 Sept. 20–23.
-
- Practice Committee of the American Society for Reproductive Medicine; Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril 2016;106:1634–47. - PubMed
-
- Petrenko AP, Castelo-Branco C, Marshalov DV, et al. . Assessing the usefulness of severity markers in women with ovarian hyperstimulation syndrome. Reprod Sci 2021;28:1041–8. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources